EHC/LinkedIn
Apr 7, 2026, 16:44
A Call to Get the Biotech Act Right for The Millions Living with Bleeding Disorders – EHC
EHC – European Haemophilia Consortium shared on LinkedIn:
”Innovation without access is not progress.
On World Health Day, the EHC is calling on EU policymakers to get the Biotech Act right for the millions living with bleeding disorders who cannot afford to wait.
Science is moving fast.
Regulation and access must keep up.
The EHC demands:
- Patients at the table, not as an afterthought, but at every stage of research, trials, and regulatory decisions
- Real-world evidence that counts, because clinical trial data alone do not capture the full picture of patients’ lives
- Cross-border clinical trials to break down barriers and bring innovation to patients across Europe, no matter where they live
The theme of World Health Day 2026 is ‘Together for health: stand with science’.
Standing with science means ensuring that science stands for patients.
The EU Biotech Act is an opportunity. Let’s not waste it.
Stay updated with Hemostasis Today.
-
May 25, 2026, 14:04Sophia Delicou: We Aim to Bridge Laboratory Insights and Clinical Practice for Unstable Hemoglobin Variants
-
May 25, 2026, 13:49Chaitanya Harita: Presenting AML Research at the British Society for Haematology Annual Scientific Meeting 2026
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 13:04Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter